Serum Uric Acid as a Predictor of Perinatal Outcome in Women with Pre-eclampsia: A prospective Cohort Study
Abstract
To assess the connotation among elevated serum uric acid (SUA) levels and adverse fetal outcomes in women with pre-eclampsia.
This Prospective, cohort study was conducted in the Department of Obstetrics & Gynecology, Fauji Foundation Hospital, Rawalpindi. Ethical approval was granted by the ERC of the hospital. A total of 60 women (30 exposed and 30 unexposed) with of age 18-40 years were included. Patients with already taking medications for hyperuricemia, chronic hypertension, CRF and severe systemic illness like 2 uncontrolled diabetes mellitus, heart diseases were excluded. Group A (exposed) included the females with serum uric acid levels ≥6 mg/dl on presentation while Group B (unexposed) included pregnant females with serum uric acid levels. Data was analyzed using SPSS-25.0
The study results indicated that 50.0% of women with serum uric acid level of ≥6 mg/dl and pre-eclampsia experienced low birth weight, whereas only 26.67% of women having a SUA level of <600 mg/dl and preeclampsia had this outcome. Additionally, 40.0% of women with pre-eclampsia and high serum uric acid levels had intrauterine growth retardation, compared to 6.67% of those with lower serum uric acid levels. NICU admission was also more common in women with serum uric acid ≥6 mg/dl (23.33%) and pre-eclampsia as compared to those with <600 mg/dl (6.67%). These findings, with a p-value of <0.05 and a relative risk of >1, signify a significant and positive association between elevated serum uric acid levels and adverse outcomes for both the fetus and the mother.
This study concluded that there is a positive association between high serum uric acid levels and adverse feto-maternal outcome.
How to Cite This Article
Mujeeb A, Tabassum H, Masoud A, Ahmed M, Bokhari NA, Fatima A. Serum Uric Acid as a Predictor of Perinatal Outcome in Women with Pre-eclampsia: A prospective Cohort Study. J Pak Soc Intern Med. 2024;5(4):723–728. doi:10.70302/jpsim.v5i4.2473
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Lean SC, Derricott H, Jones RL, Heazell AE. Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis. PloS one. 2017 Oct 17;12(10):e0186287.
- Saeed S, Jamal A, Rafiq FA, Rafiq F, Jamal A. Frequency of hypocalcemia in women with preeclampsia at a tertiary care hospital. Pakistan J Med Heal Sci. 2017 Apr 1;11(2):773-6.
- Le TM, Nguyen LH, Phan NL, Le DD, Nguyen HVQ, Truong VQ, et al. Maternal serum uric acid concentration and pregnancy outcomes in women with preeclampsia/eclampsia. Int J Gynecol Obstet. 2019;144:21–6
- Aelie R, Jun CN, Sook KY, Young LE. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Med. 2019;98(18):e15462.
- Kanagal DV, Rajesh A, Rao K, Devi UH, Shetty H, Kumari S, et al. Levels of serum calcium and magnesium in pre-eclamptic and normal pregnancy: a study from Coastal India. J Clin Diagn Res. 2014;8(7):OC01–OC04.
- Essiben F, Itembe O, Foumane P, Nguefack MT, Eko FE. Blood uric acid level as a marker of increased risk of eclampsia in severe pre‐eclamptic patients: A cross‐ sectional study in two tertiary hospitals of Yaoundé, Cameroon. Health Sci Dis. 2016;17:7–11.
- Alzuabidi ZFM. The role of uric acid in predicting preeclampsia. Women. J Chem Pharmaceut Res. 2016;8(4):1175-79.
- Reynolds C, Mabie WC, Sibai BM. "Pre-eclampsia". Pregnancy - Hypertensive Disorders. Arm Med Network. 2006; Retrieved 2006-11-23.
- Lykke JA, Paidas MJ, Langhoff-Roos J. Recurring complications in second pregnancy. Obstet Gynecol. 2009;113(6):1217-24.
- Alzuabidi ZFM. The role of uric acid in predicting preeclampsia. Women. J Chem Pharmaceut Res. 2016;8(4):1175-79.
- Kumar N, Singh AK. Maternal serum uric acid as a predictor of severity of hypertensive disorders of pregnancy: a prospective cohort study. Curr Hypertens Rev. 2019;15(2):154–60.
- Toshniwal S, Lamba AR. Serum uric acid as marker of severity of pre-eclampsia. Int J Reprod Contracept Obstet Gynecol. 2017;6(11):4915-7.
- Nair A, Savitha C. Estimation of serum uric acid as an indicator of severity of preeclampsia and perinatal outcome. J Obst Gynecol India. 2017;67(2):109-18.
- Shand A, Nassar N, Von Dadelszen P, Innis S, Green T. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for preeclampsia. BJOG. 2010;117(13):
- Chappell LC, Cluver CA, Tong S. Pre-eclampsia. The Lancet. 2021 Jul 24;398(10297):341-54.
- Martin AC, Brown MA. Could uric acid have a pathogenic role inpreeclampsia? Nat Rev Nephrol 2010;6:744–8.
- Bainbridge SA, Deng JS, Roberts JM. Increased xanthine oxidase inthe skin of pre-eclamptic women. Reprod Sci 2009;16:468–78
- Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia.Am J Pathol 2000;156:321–31
- Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor inpreeclampsia. Placenta 2008;22:S67–72
- Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk.N Engl J Med 2008;359:1811–21
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.